Skip to main content

Market Overview

Benzinga's Top #PreMarket Gainers

Share:

Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 6.44 percent to $3.80 in pre-market trading. JP Morgan initiated coverage on Idera Pharmaceuticals with a Overweight rating.

Plasmatech Biopharmaceuticals Inc (NASDAQ: PTBI) shares rose 5.05 percent to $7.70 in pre-market trading following the announcement of license deal for gene therapy in Fanconi anemia, CRISPR/Cas9-Based technology platform.

bluebird bio Inc (NASDAQ: BLUE) shares rose 4.98 percent to $189.82 in pre-market trading after the company reported new data from HGB-205 study. Philip Gregory, D. Phil., joined bluebird bio as Chief Scientific Officer. JP Morgan maintained bluebird bio with a Overweight and raised the price target from $200.00 to $244.00.

Trivascular Technologies Inc (NASDAQ: TRIV) shares climbed 3.91 percent to $7.18 in pre-market trading after the company reported the FDA approval of Ovation iX(TM) Iliac Stent Graft.

Standard Pacific Corp. (NYSE: SPF) shares climbed 1.80 percent to $8.50 in pre-market trading. Standard Pacific and Ryland Group Inc (NYSE: RYL) agreed to merge in an all-stock transaction.

 

Related Articles (BLUE + TRIV)

View Comments and Join the Discussion!

Posted-In: Premarket MoversNews Pre-Market Outlook Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com